Developmental Expression and Dysregulation of miR-146a and miR-155 in Down's Syndrome and Mouse Models of Down's Syndrome and Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|14|12|1305-1317

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.14, Iss.12, 2017-10, pp. : 1305-1317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 13, Iss. 1, 2016-01 ,pp. : 53-67

Bentham Science Publishers

Access to resources Recommend Favorite

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome

By  

Current Alzheimer Research, Vol. 13, Iss. 1, 2016-01 ,pp. : 35-52

Bentham Science Publishers

Access to resources Recommend Favorite

Salvianolate Blocks Apoptosis During Myocardial Infarction by Down Regulating miR-122-5p

By  

Current Neurovascular Research, Vol. 14, Iss. 4, 2018-01 ,pp. : 323-329

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease and Down Syndrome: From Meiosis to Dementia

By Petronis A.  

Experimental Neurology, Vol. 158, Iss. 2, 1999-08 ,pp. : 403-413

Elsevier

Access to resources Recommend Favorite

Aging in Down Syndrome and the Development of Alzheimer’s Disease Neuropathology

By  

Current Alzheimer Research, Vol. 13, Iss. 1, 2016-01 ,pp. : 18-29

Bentham Science Publishers

Access to resources Recommend Favorite